Sarecycline is a semi-synthetic derivative of tetracycline that was initially discovered by Paratek Pharmaceuticals from Boston, MA but then licensed to Warner Chilcott of Rockaway, NJ in July of 2007 . After completing various phase-II and phase-III trials demonstrating its effectiveness in treating moderate to severe facial acne vulgaris the US Food and D...
用于治疗9岁以上人群的中重度痤疮【美国FDA已批准】。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.